Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024

Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024

Mont-Saint-Guibert, Belgium – October 22, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will release financial results for the third quarter 2024 on Wednesday, November 6, 2024, after market close. Company management will host a conference call to discuss financial results that day beginning at 10:30pm CET / 4:30pm ET.

A webcast of the call will be accessible via the Investor Relations page of the Nyxoah website or through this link: Nyxoah's Q3 2024 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast.

If you plan to ask a question, please use the following link: Nyxoah’s Q3 2024 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call.

The archived webcast will be available for replay shortly after the close of the call.

About Nyxoah
Nyxoah is reinventing sleep for the billion people that suffer from obstructive sleep apnea (OSA). We are a medical technology company that develops breakthrough treatment alternatives for OSA through neuromodulation. Our first innovation is Genio®, a battery-free hypoglossal neuromodulation device that is inserted through a single incision under the chin and controlled by a wearable. Through our commitment to innovation and clinical evidence, we have shown best-in-class outcomes for reducing OSA burden.

Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company announced positive outcomes from the DREAM IDE pivotal study for FDA and U.S. commercialization approval.

Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.

FORWARD-LOOKING STATEMENTS

Certain statements, beliefs and opinions in this press release are forward-looking, which reflect the Company's or, as appropriate, the Company directors' or managements' current expectations regarding the Genio® system; planned and ongoing clinical studies of the Genio® system; the potential advantages of the Genio® system; Nyxoah’s goals with respect to the development, regulatory pathway and potential use of the Genio® system; the utility of clinical data in potentially obtaining FDA approval of the Genio® system; and reporting data from Nyxoah’s DREAM U.S. pivotal trial; receipt of FDA approval; entrance to the U.S. market; and the anticipated closing and use of the proceeds from the offering. By their nature, forward-looking statements involve a number of risks, uncertainties, assumptions and other factors that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties, assumptions and factors could adversely affect the outcome and financial effects of the plans and events described herein. Additionally, these risks and uncertainties include, but are not limited to, the risks and uncertainties set forth in the “Risk Factors” section of the Company’s Annual Report on Form 20-F for the year ended December 31, 2023, filed with the Securities and Exchange Commission (“SEC”) on March 20, 2024, and subsequent reports that the Company files with the SEC. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward looking statements contained in this press release regarding past trends or activities are not guarantees of future performance and should not be taken as a representation that such trends or activities will continue in the future. In addition, even if actual results or developments are consistent with the forward-looking statements contained in this press release, those results or developments may not be indicative of results or developments in future periods. No representations and warranties are made as to the accuracy or fairness of such forward-looking statements. As a result, the Company expressly disclaims any obligation or undertaking to release any updates or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based, except if specifically required to do so by law or regulation. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person's officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.

This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities in the offering, nor shall there be any sale of these securities in any jurisdiction in which an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.

Contacts:

Nyxoah
Loïc Moreau, Chief Financial Officer
IR@nyxoah.com

For Media
In United States
FINN Partners – Glenn Silver
glenn.silver@finnpartners.com

In Belgium/France
Backstage Communication – Gunther De Backer
gunther@backstagecom.be

In International/Germany
MC Services – Anne Hennecke
nyxoah@mc-services.eu

Attachment

  • ENGLISH_Q3 2024 Earnings Call Save-the-Date


Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024

THỦ THUẬT HAY

Trọn bộ Full key active office 2016 bản quyền mới nhất 2023 [ hoạt động 24/7]

Bạn đang muốn tìm kiếm bộ key active office 2016 nhưng không tìm kiếm được nguồn đáng tin cậy. Mua bản chính thức từ Microsoft hoặc các đại lý phối thì giá rất cao. Nếu không chia sẻ với nhiều người thì rất lãng phí.

Hỏi và đáp 360 độ tổng hợp về 4G Viettel

Thời gian gần đây, 4G Viettel trở thành một từ khóa nóng nhất với người dùng yêu thích công nghệ trên toàn quốc. Khắp các tỉnh thành, khách hàng của Viettel nô nức đi đổi sang sim 4G. Vậy đâu là lý do khiến khách hàng

+ 99 ý tưởng trang trí nhà ngày Tết sang trọng, độc đáo nhất năm 2023

Bên cạnh việc chuẩn bị đồ ăn thức uống ngày Tết thì trang trí nhà ngày Tết cũng là một phần không thể thiếu. Chỉ cần một vài thao tác trang trí nhà đơn giản sẽ giúp không gian nhà bạn ngập tràn không khí Tết, đón một

Cách đóng bảo hiểm y tế online nhanh chóng, tiện lợi

Hiện tại, đã có khá nhiều cách cách đóng bảo hiểm y tế online tại nhà vừa tiết kiệm thời gian, vừa tránh tiếp xúc với nhiều người.

[Mac] Dùng Vox để nghe Youtube

Vox là phần mềm miễn phí trên App Store. Mình vẫn dùng nó để nghe FLAC và các chuẩn âm thanh mà iTune không hỗ trợ. Mình cũng thường xuyên nghe nhạc trên Youtube. Hồi xưa chưa biết...

ĐÁNH GIÁ NHANH

Trên tay OPPO A93s: Smartphone tầm trung sở hữu màn hình 90Hz, chip Dimensity 700, pin khủng 5000 mAh

Mới đây, OPPO đã tung ra một mẫu điện thoại tầm trung hoàn toàn mới tại thị trường Trung Quốc có tên là OPPO A93s. Sản phẩm có thiết kế khác biệt so với OPPO A93 hiện đang bán tại thị trường Việt Nam. Bên cạnh đó, các

Có nên mua iPad mini 6 không?5 lý do dưới đây sẽ giúp bạn giải đáp

iPad mini 6 được Apple trình làng cùng iPhone 13 series hồi tháng 9 và hiện đã lên kệ tại nhiều quốc gia. Thuộc thương hiệu cao cấp nhưng không ít bạn vẫn đắn đo có nên mua iPad mini 6 không. Bài viết này sẽ đưa ra 5

Đánh giá Isuzu mu-X: thế lực mới trong làng SUV 7 chỗ phổ dụng

Vào Việt Nam, Isuzu mu-X cạnh tranh với Fortuner và Pajero Sport, làm gợi lại cuộc đấu tay ba giữa Isuzu Hi-Lander, Mitsubishi Jolie và Toyota Zace những năm đầu thế kỷ 21.